• Kyodo

  • SHARE

A Japanese team reported Thursday that five patients with a severe eye disease were doing well after they received in 2017 the world’s first transplant surgeries using induced pluripotent stem cells, known as iPS cells, from donors.

As part of a clinical research program, the patients received the transplants of artificially grown retinal cells made from donor iPS cells as a treatment for wet-type age-related macular degeneration, which can often lead to blindness.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)